Solara Active Pharma Sciences
add_icon

Solara Active Pharma Sciences

540.00
+1.15
(0.21%)
Market Cap
1,953.33 Cr
PE Ratio
-346.97
Volume
15.00
Day High - Low
545.45 - 534.05
52W High-Low
734.40 - 422.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
1,953.33 Cr
EPS
-1.68
PE Ratio
-346.97
PB Ratio
2.04
Book Value
263.26
EBITDA
180.86
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
0.05
Debt to Equity
0.89
Forecast For
Actual

Company News

View All News
Caret
neutral
Solara Active Pharma Sciences adopted a Board Evaluation Policy and amended its Whistle Blower Policy at its Board meeting held on May 15, 2026.
positive
Solara Active Pharma Sciences reports Q4 FY26 revenue of Rs. 387.29 crores (+40% YoY) and net profit of Rs. 9.60 crores; publishes newspaper advertisement for audited FY26 results.
neutral
Solara Active Pharma Sciences reappoints Grant Thornton Bharat LLP as Internal Auditors and Mr. K. Suryanarayanan as Cost Auditors for FY 2026-27, effective May 15, 2026.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,787.00
#1 4,28,761.16
37.30
#1 58,220.10
6.38
#1 11,565
25.80
44.37
6,565.00
1,74,280.12
67.97
10,560.00
8.73
2,520
13.44
46.75
4,370.00
1,47,900.66
69.16
13,886.20
20.34
2,138
-26.91
50.11
1,373.20
1,10,924.44
28.76
27,711.70
-2.46
3,783
-55.32
52.65
1,076.00
1,08,270.78
21.14
26,719.70
13.65
5,242
7.82
68.91
1,261.90
1,05,323.60
25.35
33,593.30
-0.44
3,998
-86.05
41.47
2,260.00
1,03,291.77
#1 19.30
27,487.50
19.98
5,345
#1 87.72
45.17
2,375.00
98,041.20
50.52
14,277.60
12.03
1,750
31.75
50.42
1,435.00
83,345.03
23.88
33,384.70
3.21
3,376
1.99
48.90
1,394.00
75,256.01
84.57
6,812.90
#1 21.03
884
21.18
76.00

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
5.95 %
Net Income Growth
-1,582.00 %
Cash Flow Change
95.48 %
ROE
-100.08 %
ROCE
-125.90 %
EBITDA Margin (Avg.)
-20.83 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Revenue
303
344
360
392
335
356
350
309
353
404
435
454
412
405
105
367
337
342
402
385
354
426
212
301
364
347
302
279
320
314
349
393
Expenses
263
295
294
321
267
283
266
247
265
300
321
345
315
330
199
349
318
311
350
332
333
393
436
412
322
286
243
228
262
279
318
330
EBITDA
40
49
66
71
68
73
84
62
88
104
114
109
97
75
-94
18
20
31
52
53
21
34
-224
-111
43
62
59
51
58
35
31
63
Operating Profit %
13 %
14 %
17 %
17 %
19 %
19 %
23 %
17 %
24 %
25 %
25 %
22 %
22 %
18 %
-98 %
3 %
4 %
8 %
11 %
13 %
5 %
8 %
-106 %
-38 %
12 %
18 %
19 %
17 %
18 %
11 %
9 %
15 %
Depreciation
19
19
21
23
23
24
24
24
26
28
27
27
28
28
28
28
28
29
28
27
26
26
26
25
25
25
25
24
24
25
26
26
Interest
18
20
23
22
19
20
19
20
20
19
21
25
19
17
18
22
23
22
24
22
25
24
25
31
31
28
27
29
24
21
23
28
Profit Before Tax
3
9
22
26
27
29
41
18
42
57
66
57
50
30
-140
-31
-31
-19
1
5
-29
-17
-275
-167
-14
8
8
-2
11
-10
-17
10
Tax
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
-33
-15
-9
0
1
-10
0
0
89
0
0
0
0
0
0
0
0
Net Profit
3
9
22
26
27
29
41
18
42
57
66
57
50
30
-140
2
-17
-10
0
4
-19
-17
-275
-255
-14
8
8
-2
11
-10
-17
10
EPS in ₹
0.23
3.47
8.96
10.17
10.29
11.21
16.00
6.78
15.75
19.21
18.47
15.57
13.95
8.27
-38.93
0.53
-4.56
-2.77
0.12
1.05
-5.43
-4.77
-72.07
-70.93
-3.50
2.54
2.03
-0.93
2.46
-2.36
-3.98
2.20

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
1,822
1,960
2,154
2,614
2,945
2,899
2,351
2,232
2,333
Fixed Assets
1,086
1,218
1,397
1,382
1,356
1,364
1,268
1,193
1,077
Current Assets
608
648
672
1,058
1,239
1,188
801
729
858
Capital Work in Progress
72
40
41
88
239
239
256
280
205
Investments
1
0
0
0
0
2
2
2
318
Other Assets
663
702
716
1,144
1,350
1,295
825
757
0
Total Equity & Liabilities
1,822
1,960
2,154
2,614
2,945
2,899
2,351
2,232
2,333
Current Liabilities
738
656
730
789
1,063
1,101
1,243
944
894
Non Current Liabilities
315
344
333
232
354
296
172
191
183
Total Equity
769
960
1,090
1,593
1,527
1,502
937
1,097
1,253
Reserve & Surplus
739
826
963
1,553
1,489
1,464
898
1,054
1,208
Share Capital
25
26
27
36
36
36
36
40
45

Cash Flow

Cash Flow
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
32
30
-20
142
-151
-38
-0
-5
Investing Activities
-86
-113
-359
-106
-243
-81
-4
-37
Operating Activities
49
166
242
156
-242
156
109
213
Financing Activities
68
-23
97
93
334
-113
-106
-181

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
May 2026
Promoter
44.11 %
41.07 %
41.07 %
39.51 %
39.71 %
40.40 %
40.40 %
40.40 %
40.97 %
39.31 %
37.19 %
30.49 %
30.49 %
37.27 %
37.27 %
37.23 %
37.94 %
42.01 %
42.01 %
42.00 %
42.00 %
42.00 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
15.80 %
14.00 %
14.25 %
14.67 %
14.63 %
14.25 %
13.58 %
11.98 %
11.59 %
11.33 %
DIIs
3.72 %
6.18 %
5.55 %
5.38 %
3.39 %
2.85 %
2.56 %
3.01 %
2.22 %
1.75 %
1.75 %
1.71 %
2.97 %
2.83 %
3.38 %
3.19 %
2.61 %
2.62 %
2.69 %
3.64 %
3.75 %
3.78 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
14.76 %
14.35 %
13.84 %
16.36 %
17.41 %
16.61 %
17.28 %
16.54 %
16.23 %
18.06 %
19.84 %
20.95 %
20.15 %
19.61 %
18.83 %
21.93 %
23.07 %
23.47 %
24.01 %
24.63 %
25.03 %
25.15 %
Others
37.41 %
38.40 %
39.53 %
38.73 %
39.48 %
40.15 %
39.76 %
40.04 %
40.58 %
40.88 %
41.22 %
46.84 %
30.59 %
26.29 %
26.28 %
22.98 %
21.74 %
17.63 %
17.70 %
17.74 %
17.63 %
17.74 %
No of Share Holders
58,907
67,197
65,449
73,000
77,228
82,710
83,319
79,149
76,325
75,417
74,473
72,918
73,912
78,617
71,882
83,148
75,791
74,334
72,479
71,920
70,400
70,037

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 5 2 7 0.00 3 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 1.22 0.16 1.14 0.00 0.88 0.00 0.00 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
25 Mar 2017 CHANGE OF NAME Change Of Name
NA
25 Mar 2017 0.00 0.00
20 Aug 2021 DIVIDEND Dividend
₹ 3.00 /share
18 Aug 2021 1,484.58 1,564.11
15 May 2024 RIGHTS Rights
1:3
15 May 2024 465.01 503.40
20 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
20 Sept 2024 694.40 736.35
21 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
21 Oct 2024 748.90 809.60
24 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
24 Jan 2025 652.85 678.80
15 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
15 May 2025 482.35 576.30
25 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
25 Jul 2025 692.85 657.35
25 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
25 Sept 2025 632.10 644.30
05 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
05 Nov 2025 588.45 617.40
06 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Feb 2026 505.55 524.15
15 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
15 May 2026 515.85 506.85

Announcements

Compliances-Reg.24(A)-Annual Secretarial Compliance5 days ago
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 21, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 16, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 15, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 15, 2026
Intimation Regarding The Adoption Or Amendments Of PoliciesMay 15, 2026
Statement Of Deviation And Variation For Funds Raised Under Rights Issue For The Quarter Ended March 31 2026.May 15, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 15, 2026
Intimation Regarding The Reappointment Of Cost Auditor And Internal AuditorMay 15, 2026
Intimation In Relation To The Rights IssueMay 15, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 15, 2026
Financial Results For The Quarter And Year Ended March 31 2026May 15, 2026
Board Meeting Outcome for Board Meeting Outcome For Audited Financial Results For The Year Ended March 31 2026 And Unaudited Financial Results For The Quarter Ended March 31 2026.May 15, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 12, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 11, 2026
Board Meeting Intimation for Intimation Regarding Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)May 08, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 28, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 09, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 08, 2026
Intimation Regarding Dispatch Of The Second And Final Call Money Notice Of The Rights Equity Shares.Apr 07, 2026
Closure of Trading WindowMar 26, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 25, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 25, 2026
General Update - Rights Issue - Second & Final CallMar 24, 2026
Corporate Action- Record Date For The Purpose Of Making Second And Final Call For Rights Equity SharesMar 24, 2026
Board Meeting Outcome for Outcome Of The Rights Issue Committee MeetingMar 24, 2026
Board Meeting Intimation for Prior Intimation Of Meeting Of Rights Issue CommitteeMar 19, 2026
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 18, 2026
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotMar 10, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 10, 2026
Receipt Of Call Money Pursuant To The Second Reminder Notice Issued For Payment Of First Call Money On Rights SharesMar 04, 2026
Intimation Regarding The Closure Of Wholly Owned Subsidiary Of The Company In Brazil.Mar 04, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 10, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 07, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 06, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 06, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 06, 2026
Statement Of Deviation And Variation For Funds Raised Under Rights Issue For The Quarter Ended December 31 2025.Feb 06, 2026
Announcement Under Regulation 30 Of SEBI (LODR) 2015 Regarding The Revision And Adoption Of Policies.Feb 06, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 06, 2026
Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended December 31 2025Feb 06, 2026
Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended December 31 2025Feb 06, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 05, 2026
Dispatch Of Second Reminder Notice For Payment Of First Call MoneyFeb 04, 2026
Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 04, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 03, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 30, 2026
Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended December 31 2025.Jan 30, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 12, 2026
Closure of Trading WindowDec 24, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.01%
3
0.00%
0.00%
Aditya Birla Sun Life Flexi Cap Fund Direct-Growth
0.08%
0
0.00%
0.00%
Aditya Birla Sun Life Manufacturing Equity Fund Direct-Growth
0.59%
0
0.00%
-0.02%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.08%
0
0.00%
0.01%

Technical Indicators

RSI(14)
Neutral
52.60
ATR(14)
Less Volatile
26.69
STOCH(9,6)
Neutral
30.51
STOCH RSI(14)
Oversold
12.33
MACD(12,26)
Bearish
-3.75
ADX(14)
Strong Trend
43.63
UO(9)
Bearish
39.64
ROC(12)
Downtrend And Accelerating
-7.08
WillR(14)
Neutral
-59.15